Business Of Biotech

IL-2 Program Profits with Bonum's Drs. John Mulligan and Neela Patel

Dec 18, 2023
Dr. Neela Patel and Dr. John Mulligan discuss Bonum Therapeutics' transition from Good Therapeutics, the Roche acquisition, challenges faced by early-stage biotech companies, and creating a better path for women in biotech.
Ask episode
Chapters
Transcript
Episode notes